Home › NDC Lookup › RxCUI directory › RxCUI 1791612

Docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Capsule — RxCUI 1791612

RxNorm drug concept · Semantic clinical drug
RxCUI 1791612 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1791612
Official nameDocusate sodium 50 MG / sennosides, USP 8.6 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asDOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Capsule; sennosides 8.6 MG / docusate sodium 50 MG Oral Capsule
FDA products mapped9
Package NDCs mapped10
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Senna: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
  • How long does it take for senna to work?
  • Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
  • Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...
📖 Read our full Senna guide →

🕸️ Concept Web — How Docusate sodium 50 MG / sennosides, USP 8.6 MG O... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Capsule RxCUI 1791612

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Docusate 82003
    • Sennosides, USP 36387
    • Docusate / sennosides, USP 1008340
    • Docusate sodium 71722
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Docusate / sennosides, USP Oral Capsule 619057
    • Docusate sodium / sennosides, USP Oral Capsule 2649174
    • Docusate / sennosides, USP Oral Product 1160195
    • Docusate / sennosides, USP Pill 1160196
    • Docusate sodium / sennosides, USP Oral Product 2660390
    • Docusate sodium / sennosides, USP Pill 2660734
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Docusate sodium 50 MG 836262
    • Sennosides, USP 8.6 MG 331847

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Docusate sodium 50 MG SCDC · 836262
  • Sennosides, USP 8.6 MG SCDC · 331847
  • Docusate / sennosides, USP Oral Capsule SCDF · 619057
  • Docusate sodium / sennosides, USP Oral Capsule SCDFP · 2649174
  • Docusate / sennosides, USP Oral Product SCDG · 1160195
  • Docusate / sennosides, USP Pill SCDG · 1160196
  • Docusate sodium / sennosides, USP Oral Product SCDGP · 2660390
  • Docusate sodium / sennosides, USP Pill SCDGP · 2660734

📦 FDA Products & Package NDCs

9 products · 10 package NDCs
10 package NDCs map to RxCUI 1791612 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-1173-60 1 BOTTLE in 1 BOX (0363-1173-60) / 60 CAPSULE, LIQUID FILLE... Senna S Walgreens 2023-10-20
00363-6683-60 1 BOTTLE, PLASTIC in 1 CARTON (0363-6683-60) / 60 CAPSULE,... Senna-S Walgreens 2025-06-11
35916-0453-01 500 CAPSULE, GELATIN COATED in 1 BOTTLE (35916-0453-1) Docusate Sodium and Sennosides SOFTGEL HEALTHCARE PRIVATE LIMITED 2024-06-04
35916-0453-03 2 POUCH in 1 BOX (35916-0453-3) / 3000 CAPSULE, GELATIN COA... Docusate Sodium and Sennosides SOFTGEL HEALTHCARE PRIVATE LIMITED 2025-06-12
35916-0454-01 500 CAPSULE, GELATIN COATED in 1 BOTTLE (35916-0454-1) Docusate Sodium and Sennosides SOFTGEL HEALTHCARE PRIVATE LIMITED 2024-06-22
35916-0477-01 2 BAG in 1 BOX (35916-0477-1) / 1500 CAPSULE, LIQUID FILLED... Docusate Sodium and Sennosides SOFTGEL HEALTHCARE PRIVATE LIMITED 2026-01-16
51316-0318-06 1 BOTTLE in 1 CARTON (51316-318-06) / 60 CAPSULE, LIQUID FI... CVS Health Stool Softener Plus stimulant laxative Softgel CVS Pharmacy, Inc 2025-03-19
72090-0054-01 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (72090-054-01) Gencare-Senna-S Softgel Pioneer Life Sciences, LLC 2025-06-30
83059-0120-06 60 CAPSULE, LIQUID FILLED in 1 BOTTLE (83059-0120-6) Senna S Shield Pharmaceuticals Corp 2025-12-05
84324-0030-01 60 CAPSULE, LIQUID FILLED in 1 BOTTLE (84324-030-01) Senna-S Softgel NUVICARE LLC 2025-06-24
Observed labelers: SOFTGEL HEALTHCARE PRIVATE LIMITED (4) · Walgreens (2) · CVS Pharmacy, Inc (1) · NUVICARE LLC (1) · Pioneer Life Sciences, LLC (1) · Shield Pharmaceuticals Corp (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.